atorvastatin has been researched along with Angioma, Cavernous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akers, AL; Awad, IA; Cao, Y; Christoforidis, GA; Fam, MD; Flemming, KD; Girard, R; Hanley, DF; Hobson, N; Koenig, JI; Koskimäki, J; Lane, K; Lee, C; Liao, JK; Lyne, SB; McBee, N; Morrison, L; Piedad, K; Polster, SP; Shenkar, R; Sorrentino, M; Stadnik, A; Thompson, RE; Whitehead, KJ; Zeineddine, HA | 1 |
1 trial(s) available for atorvastatin and Angioma, Cavernous
Article | Year |
---|---|
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.
Topics: Atorvastatin; Cerebral Hemorrhage; Double-Blind Method; Female; Follow-Up Studies; Hemangioma, Cavernous; Hemangioma, Cavernous, Central Nervous System; Humans; Magnetic Resonance Imaging; Male; Proof of Concept Study; Prospective Studies; Protein Kinase Inhibitors; rhoA GTP-Binding Protein; Treatment Outcome | 2019 |